Product Information
PROPAFENONE HCL 300 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.3880 per EA under NDC 59651025801. Its NADAC has been published 317 times since Sep 9, 2020.
FDA first approved this application on May 11, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
59651025801
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202445FDA Approved
5/11/2016
TE Code
AB
On Market Since
10/25/2019
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL 300 MG TAB has been published 317 times since Sep 9, 2020, and over the history we have for it it has declined 29.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3880 per EA |
|---|---|
| All-time high | $0.7571 (Jul 14, 2021) |
| All-time low | $0.2331 (Nov 20, 2024) |
| 52-week high | $0.5292 |
| 52-week low | $0.3880 |
| Median price | $0.4781 |
| Average price | $0.4849 |
| Largest weekly change | -42.9% (Mar 20, 2024) |
| Weeks tracked | 317 |
| Tracking since | Sep 9, 2020 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PROPAFENONE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL 300 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.3880 per EA (NDC 59651025801), effective Sep 30, 2026.
How has the price of PROPAFENONE HCL 300 MG TAB changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL 300 MG TAB has declined 29.5%. It has been tracked across 317 weekly CMS publications since Sep 9, 2020.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL 300 MG TAB?
Since Sep 9, 2020, the NADAC for PROPAFENONE HCL 300 MG TAB has ranged from a low of $0.2331 (Nov 20, 2024) to a high of $0.7571 (Jul 14, 2021), with a median of $0.4781 per EA.
Are there cheaper alternatives to PROPAFENONE HCL 300 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PROPAFENONE HCL 300 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures PROPAFENONE HCL 300 MG TAB?
PROPAFENONE HCL 300 MG TAB (NDC 59651025801) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.